Biora Therapeutics, Inc. Derivative Liability, Current
Biora Therapeutics, Inc. had Derivative Liability, Current of $35.02 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2024-11-14
- 2024-09-30: Derivative Liability, Current $35.02M.
- 2024-06-30: Derivative Liability, Current $17.00M.
- 2024-03-31: Derivative Liability, Current $27.21M.
- 2023-12-31: Derivative Liability, Current $0.00; Derivative Liability, Current as first filed $40.83M.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2024-09-30 | $35.02M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $17.00M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $27.21M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-14 | $40.83M 10-K · filed 2024-04-01 |
| 2023-10-31 | $6.70M 10-Q · filed 2024-11-14 | |
| 2023-09-30 | $41.33M 10-Q · filed 2023-11-13 | |
| 2023-09-18 | $35.10M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $10.84M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.67M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.54M 10-K · filed 2024-04-01 | |
| 2022-11-30 | $6.00M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $3.29M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.33M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $9.74M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $18.73M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $42.40M 10-Q · filed 2021-11-10 |